Fudan University: Colorectal Neoplasms trials

The registry lists 118 Colorectal Neoplasms studies with Fudan University as lead sponsor. 60 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 56Phase 3 14Phase 4 7No phase 39(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)Status unknownNCT02965248Phase 3
• FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer PatientsStatus unknownNCT02935764Phase 3
• Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal CancerStatus unknownNCT02618356Phase 2
• Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer PatientsStatus unknownNCT02415829Phase 2
• Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer PatientsStatus unknownNCT02376452Phase 2
• wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer PatientsStatus unknownNCT01736904Phase 2
• Serum Proteomic Profiling for the Early Diagnosis of Colorectal CancerCompletedNCT01604798
• Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer PatientsStatus unknownNCT01322178Phase 2
• Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal CancerCompletedNCT01322152Phase 2
• Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal CancerStatus unknownNCT01310478Phase 1
• New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited MetastasesCompletedNCT01307878Phase 3
• S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal CancerStatus unknownNCT01193452Phase 2
• Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal CancerStatus unknownNCT00874406Phase 4
• Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal CancerCompletedNCT00869271Phase 4
• Oxaliplatine Based Adjuvant Chemotherapy for Stage II/III Colorectal Cancer: 8 Cycles Versus 12 CyclesCompletedNCT00868816Phase 4
• Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal CancerStatus unknownNCT00868569Phase 4
• Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin TreatmentStatus unknownNCT00839111Phase 2
• Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal CancerStatus unknownNCT00643877Phase 3